持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/12/03 | 4,485 | 4,495 | 4,435 | 4,460 | -15 | -0.3% | 55,900 |
2019/12/02 | 4,445 | 4,485 | 4,440 | 4,475 | +75 | +1.7% | 39,700 |
2019/11/29 | 4,455 | 4,460 | 4,400 | 4,400 | -30 | -0.7% | 42,900 |
2019/11/28 | 4,450 | 4,450 | 4,400 | 4,430 | -30 | -0.7% | 45,200 |
2019/11/27 | 4,460 | 4,500 | 4,460 | 4,460 | +15 | +0.3% | 46,000 |
2019/11/26 | 4,480 | 4,480 | 4,440 | 4,445 | +5 | +0.1% | 50,000 |
2019/11/25 | 4,465 | 4,480 | 4,410 | 4,440 | +15 | +0.3% | 30,200 |
2019/11/22 | 4,425 | 4,465 | 4,380 | 4,425 | ±0 | ±0% | 56,900 |
2019/11/21 | 4,440 | 4,470 | 4,350 | 4,425 | -35 | -0.8% | 43,400 |
2019/11/20 | 4,430 | 4,465 | 4,400 | 4,460 | +40 | +0.9% | 55,400 |
2019/11/19 | 4,380 | 4,430 | 4,375 | 4,420 | +40 | +0.9% | 45,200 |
2019/11/18 | 4,350 | 4,385 | 4,345 | 4,380 | +15 | +0.3% | 51,300 |
2019/11/15 | 4,325 | 4,380 | 4,325 | 4,365 | +65 | +1.5% | 55,400 |
2019/11/14 | 4,345 | 4,345 | 4,290 | 4,300 | -30 | -0.7% | 46,200 |
2019/11/13 | 4,390 | 4,395 | 4,330 | 4,330 | -45 | -1% | 54,700 |
2019/11/12 | 4,340 | 4,380 | 4,325 | 4,375 | +30 | +0.7% | 49,800 |
2019/11/11 | 4,380 | 4,415 | 4,345 | 4,345 | -15 | -0.3% | 42,400 |
2019/11/08 | 4,400 | 4,400 | 4,325 | 4,360 | -15 | -0.3% | 77,000 |
2019/11/07 | 4,415 | 4,420 | 4,360 | 4,375 | -25 | -0.6% | 61,300 |
2019/11/06 | 4,445 | 4,445 | 4,300 | 4,400 | +10 | +0.2% | 84,200 |
2019/11/05 | 4,325 | 4,465 | 4,265 | 4,390 | +150 | +3.5% | 125,700 |
2019/11/01 | 4,300 | 4,300 | 4,220 | 4,240 | -100 | -2.3% | 51,500 |
2019/10/31 | 4,350 | 4,405 | 4,295 | 4,340 | -5 | -0.1% | 86,800 |
2019/10/30 | 4,275 | 4,350 | 4,265 | 4,345 | +100 | +2.4% | 143,300 |
2019/10/29 | 4,275 | 4,280 | 4,220 | 4,245 | +20 | +0.5% | 75,800 |
2019/10/28 | 4,265 | 4,265 | 4,185 | 4,225 | -35 | -0.8% | 50,900 |
2019/10/25 | 4,215 | 4,260 | 4,185 | 4,260 | +75 | +1.8% | 66,700 |
2019/10/24 | 4,220 | 4,220 | 4,155 | 4,185 | +10 | +0.2% | 50,200 |
2019/10/23 | 4,135 | 4,175 | 4,080 | 4,175 | +80 | +2% | 49,600 |
2019/10/21 | 4,120 | 4,135 | 4,070 | 4,095 | -35 | -0.8% | 38,300 |
2019/10/18 | 4,165 | 4,215 | 4,115 | 4,130 | -20 | -0.5% | 47,500 |
2019/10/17 | 4,195 | 4,195 | 4,105 | 4,150 | -40 | -1% | 78,400 |
2019/10/16 | 4,215 | 4,245 | 4,175 | 4,190 | +35 | +0.8% | 80,400 |
2019/10/15 | 4,130 | 4,180 | 4,130 | 4,155 | +100 | +2.5% | 71,400 |
2019/10/11 | 4,080 | 4,080 | 4,030 | 4,055 | +5 | +0.1% | 43,600 |
2019/10/10 | 4,075 | 4,090 | 4,015 | 4,050 | -40 | -1% | 41,000 |
2019/10/09 | 4,030 | 4,090 | 4,005 | 4,090 | +25 | +0.6% | 56,900 |
2019/10/08 | 4,030 | 4,065 | 3,995 | 4,065 | +85 | +2.1% | 55,500 |
2019/10/07 | 4,000 | 4,000 | 3,960 | 3,980 | -40 | -1% | 38,800 |
2019/10/04 | 4,000 | 4,025 | 3,940 | 4,020 | ±0 | ±0% | 77,300 |
2019/10/03 | 4,020 | 4,025 | 3,970 | 4,020 | -105 | -2.5% | 66,000 |
2019/10/02 | 4,150 | 4,200 | 4,110 | 4,125 | -35 | -0.8% | 44,800 |
2019/10/01 | 4,130 | 4,170 | 4,125 | 4,160 | +30 | +0.7% | 45,000 |
2019/09/30 | 4,090 | 4,190 | 4,090 | 4,130 | -20 | -0.5% | 58,700 |
2019/09/27 | 4,175 | 4,175 | 4,090 | 4,150 | -80 | -1.9% | 54,800 |
2019/09/26 | 4,275 | 4,290 | 4,215 | 4,230 | -15 | -0.4% | 54,700 |
2019/09/25 | 4,300 | 4,300 | 4,195 | 4,245 | ±0 | ±0% | 46,000 |
2019/09/24 | 4,220 | 4,295 | 4,220 | 4,245 | +30 | +0.7% | 52,600 |
2019/09/20 | 4,240 | 4,255 | 4,185 | 4,215 | +10 | +0.2% | 54,300 |
2019/09/19 | 4,155 | 4,240 | 4,155 | 4,205 | +80 | +1.9% | 49,700 |
1401~
1450
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 311,500円 | +7.9% | -3.3% | 2.57% | 8.66倍 | 0.89倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム